Wolfgang Brück

Pathology and Forensic Medicine · 2000–2018

A researcher in the Science corpus: 15 papers; trusts 4 researchers and is trusted by 3 researchers here, as inferred from the citation graph.

Subfields

• Pathology and Forensic Medicine — 56 citations into it; #97 of 414 by trust here, #33 by citations
• Neurology — 55 citations into it; #449 of 1,455 by trust here, #91 by citations
• Rheumatology — 18 citations into it; #74 of 221 by trust here, #21 by citations

Whom Wolfgang Brück trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

1. C. Lucchinetti

Who trusts Wolfgang Brück overall

1. Hans Lassmann

Papers from Wolfgang Brück's perspective

Ordered by how strongly the researchers Wolfgang Brück trusts endorse each paper. Same corpus, a different order for every researcher.

1. Multiple sclerosis and chronic autoimmune encephalomyelitis: a comparative quantitative study of axonal injury in active, inactive, and remyelinated lesions. (American Journal of Pathology)
2. Multiple Sclerosis (Journal - Michigan State Medical Society)
3. Why does remyelination fail in multiple sclerosis? (Nature Reviews Neuroscience)
4. NG2-Positive Oligodendrocyte Progenitor Cells in Adult Human Brain and Multiple Sclerosis Lesions (Journal of Neuroscience)
5. Multiple sclerosis--the plaque and its pathogenesis. (New England Journal of Medicine)
6. Revised diagnostic criteria for neuromyelitis optica (Neurology)
7. A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. (The Lancet)
8. Early clinical predictors and progression of irreversible disability in multiple sclerosis: an amnesic process. (Brain : a journal of neurology)
9. Mitochondrial dysfunction as a cause of axonal degeneration in multiple sclerosis patients (Annals of Neurology)
10. Neuropathological stageing of Alzheimer-related changes

Their papers

• Remyelination is extensive in a subset of multiple sclerosis patients. (2006) — 816 citations
• DNA methylation-based classification of central nervous system tumours (2018) — 2,473 citations
• Fumaric acid esters exert neuroprotective effects in neuroinflammation via activation of the Nrf2 antioxidant pathway. (2011) — 1,091 citations
• An updated histological classification system for multiple sclerosis lesions (2016) — 621 citations
• Clinical and Pathological Insights into the Dynamic Nature of the White Matter Multiple Sclerosis Plaque (2015) — 668 citations
• A reversible form of axon damage in experimental autoimmune encephalomyelitis and multiple sclerosis (2011) — 713 citations
• Inflammatory Cortical Demyelination in Early Multiple Sclerosis (2011) — 1,035 citations
• Differentiation block of oligodendroglial progenitor cells as a cause for remyelination failure in chronic multiple sclerosis. (2008) — 840 citations
• The Immunopathology of Multiple Sclerosis: An Overview (2007) — 1,172 citations
• Microglia in the adult brain arise from Ly-6ChiCCR2+ monocytes only under defined host conditions (2007) — 1,079 citations
• Cortical demyelination and diffuse white matter injury in multiple sclerosis. (2005) — 1,850 citations
• Acute axonal damage in multiple sclerosis is most extensive in early disease stages and decreases over time. (2002) — 828 citations
• Heterogeneity of multiple sclerosis pathogenesis: implications for diagnosis and therapy. (2001) — 687 citations
• Acute axonal injury in multiple sclerosis. Correlation with demyelination and inflammation. (2000) — 961 citations
• Heterogeneity of multiple sclerosis lesions: Implications for the pathogenesis of demyelination (2000) — 3,423 citations